153 related articles for article (PubMed ID: 19660655)
1. Controlled dissemination of AAV vectors in the primate brain.
Varenika V; Kells AP; Valles F; Hadaczek P; Forsayeth J; Bankiewicz KS
Prog Brain Res; 2009; 175():163-72. PubMed ID: 19660655
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy and transplantation in the retinofugal pathway.
Harvey AR; Hellström M; Rodger J
Prog Brain Res; 2009; 175():151-61. PubMed ID: 19660654
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats.
Müller OJ; Schinkel S; Kleinschmidt JA; Katus HA; Bekeredjian R
Gene Ther; 2008 Dec; 15(23):1558-65. PubMed ID: 18615116
[TBL] [Abstract][Full Text] [Related]
4. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
Maheshri N; Koerber JT; Kaspar BK; Schaffer DV
Nat Biotechnol; 2006 Feb; 24(2):198-204. PubMed ID: 16429148
[TBL] [Abstract][Full Text] [Related]
5. Clinical gene therapy using recombinant adeno-associated virus vectors.
Mueller C; Flotte TR
Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
[TBL] [Abstract][Full Text] [Related]
6. Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy.
Lai Y; Li D; Yue Y; Duan D
Methods Mol Biol; 2008; 433():259-75. PubMed ID: 18679629
[TBL] [Abstract][Full Text] [Related]
7. Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.
Michelfelder S; Lee MK; deLima-Hahn E; Wilmes T; Kaul F; Müller O; Kleinschmidt JA; Trepel M
Exp Hematol; 2007 Dec; 35(12):1766-76. PubMed ID: 17920758
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
Terzi D; Zachariou V
Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
Sakurai F; Nakamura SI; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
Gene Ther; 2009 Feb; 16(2):297-302. PubMed ID: 18800152
[TBL] [Abstract][Full Text] [Related]
11. Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors.
Kunze M; Huber A; Krajewski A; Lowden E; Schuhmann N; Buening H; Hallek M; Noack M; Perabo L
J Dent; 2009 Jul; 37(7):502-8. PubMed ID: 19362764
[TBL] [Abstract][Full Text] [Related]
12. Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models.
Richardson RM; Larson PS; Bankiewicz KS
Neurosurgery; 2008 Oct; 63(4):629-442; dicussion 642-4. PubMed ID: 18981876
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy progress and prospects: viral trafficking during infection.
Campbell EM; Hope TJ
Gene Ther; 2005 Sep; 12(18):1353-9. PubMed ID: 16151445
[TBL] [Abstract][Full Text] [Related]
14. Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties.
Koerber JT; Schaffer DV
Methods Mol Biol; 2008; 434():161-70. PubMed ID: 18470644
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates.
Lawlor PA; Bland RJ; Mouravlev A; Young D; During MJ
Mol Ther; 2009 Oct; 17(10):1692-702. PubMed ID: 19638961
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain.
Broekman ML; Tierney LA; Benn C; Chawla P; Cha JH; Sena-Esteves M
Gene Ther; 2009 Feb; 16(2):303-8. PubMed ID: 18818671
[TBL] [Abstract][Full Text] [Related]
17. Manufacturing and characterizing AAV-based vectors for use in clinical studies.
Wright JF
Gene Ther; 2008 Jun; 15(11):840-8. PubMed ID: 18418418
[TBL] [Abstract][Full Text] [Related]
18. Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates.
Butti E; Bergami A; Recchia A; Brambilla E; Franciotta D; Cattalini A; Stornaiuolo A; Lachapelle F; Comi G; Mavilio F; Martino G; Furlan R
Gene Ther; 2008 Feb; 15(3):233-8. PubMed ID: 17960158
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
Goehringer C; Rutschow D; Bauer R; Schinkel S; Weichenhan D; Bekeredjian R; Straub V; Kleinschmidt JA; Katus HA; Müller OJ
Cardiovasc Res; 2009 Jun; 82(3):404-10. PubMed ID: 19218289
[TBL] [Abstract][Full Text] [Related]
20. MRI-Guided Delivery of Viral Vectors.
Salegio EA; Bringas J; Bankiewicz KS
Methods Mol Biol; 2016; 1382():217-30. PubMed ID: 26611589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
